Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIb and IV Non Small Cell Lung Cancer”

543 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 543 results

Testing effectiveness (Phase 2)Study completedNCT00305786
What this trial is testing

Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Miami 30
Testing effectiveness (Phase 2)Study completedNCT01750281
What this trial is testing

Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.

Who this might be right for
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
AstraZeneca 212
Large-scale testing (Phase 3)UnknownNCT02859077
What this trial is testing

EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism

Who this might be right for
Non-Small-Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 100
Large-scale testing (Phase 3)UnknownNCT00955695
What this trial is testing

Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Cancer Center, Korea 242
Testing effectiveness (Phase 2)Study completedNCT00550537
What this trial is testing

Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 116
Testing effectiveness (Phase 2)Study completedNCT00126581
What this trial is testing

Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

Who this might be right for
Lung AdenocarcinomaLung Adenosquamous CarcinomaMalignant Pericardial Effusion+4 more
National Cancer Institute (NCI) 188
Testing effectiveness (Phase 2)Study completedNCT00986674
What this trial is testing

Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 140
Testing effectiveness (Phase 2)Study completedNCT00278460
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Wake Forest University Health Sciences 49
Testing effectiveness (Phase 2)Study completedNCT00227708
What this trial is testing

Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
UNICANCER 58
Testing effectiveness (Phase 2)Study completedNCT00407550
What this trial is testing

Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Mayo Clinic 19
Not applicableStudy completedNCT00898417
What this trial is testing

Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab

Who this might be right for
Lung Cancer
ECOG-ACRIN Cancer Research Group 90
Testing effectiveness (Phase 2)UnknownNCT00006215
What this trial is testing

Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Amgen
Early research (Phase 1)Study completedNCT01727076
What this trial is testing

Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck CarcinomaRecurrent Non-Small Cell Lung Carcinoma+11 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00066768
What this trial is testing

Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT02119650
What this trial is testing

Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer

Who this might be right for
NSCLC (Non-small Cell Lung Carcinoma)
Incyte Corporation 76
Not applicableStudy completedNCT00303901
What this trial is testing

Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery

Who this might be right for
Lung CancerMetastatic Cancer
Barbara Ann Karmanos Cancer Institute 40
Not applicableWithdrawnNCT02017925
What this trial is testing

Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation

Who this might be right for
CachexiaFatiguePulmonary Complications+5 more
Ohio State University Comprehensive Cancer Center
Early research (Phase 1)WithdrawnNCT01383668
What this trial is testing

Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerSquamous Cell Lung CancerStage IIIA Non-small Cell Lung Cancer+3 more
Mayo Clinic
Not applicableNot Yet RecruitingNCT05988697
What this trial is testing

Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib

Who this might be right for
NSCLCBRAF V600E MutationAdvanced Cancer+2 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 36
Large-scale testing (Phase 3)Ended earlyNCT00558636
What this trial is testing

A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bayer 91
Next Page